Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweorto AB
AB
Active
Org 5566261821
S:T Johannesgatan 2, 211 46
Malmö
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2002 · 24 years old
7 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Sweorto AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AM
Annie Maria Sande
Chief Auditor
Chief Auditor
2021
Former (2)
CS
Carl-Henrik Stefan Langdal
Authorized Recipient of Service
Authorized Recipient of Service
2020 – 2022
PT
Pär Thomas Nilsson
Chief Auditor
Chief Auditor
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
KB
Karel Budka
Board of Directors
Board of Directors
2024
HJ
Hans Joakim Bursell
Chairman
Chairman
2022
KR
Karel Rajchert
Board of Directors
Board of Directors
2025
Former (3)
XC
Xavier Cherbavaz
Chairman
Chairman
2020 – 2022
ML
Maria Luisa Caggiula
Board of Directors
Board of Directors
2020 – 2024
SA
Steven Albert Put
Board of Directors
Board of Directors
2020 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nobel Biocare AB
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Sweorto AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network